Companies: 10,795·Total market cap: $144.5T
CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSPNASDAQHealthcare● Active
$4.93
$-0.08(-1.50%)
Market Cap$2829807
P/E Ratio
52W High$12.84
52W Low$1.9
Overview

CNS Pharmaceuticals, Inc. (CNSP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CNSP · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-29.63cnsp eps ttm · cnsp earnings per shareEarnings history
PE Ratio (TTM)cnsp pe ratio ttm · cnsp price to earningsPE Ratio deep dive
Revenue (TTM)0.00cnsp revenue ttm · cnsp annual revenueFull revenue history
Dividend YieldNo Dividenddoes cnsp pay dividends · cnsp dividend yieldDividend history
Shares Outstanding443,369cnsp shares outstanding · cnsp floatShares outstanding history
Next EarningsAug 17, 2026Est.cnsp earnings date · cnsp next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
cns pharmaceuticals, inc. revenue · cnsp revenue 2025
FY 2025Net Income-$15.9M▼ 6.68% YoY
202320242025
cns pharmaceuticals, inc. net income · cnsp profit 2025
FY 2025EPS$-35.75▲ +92.34% YoY
202320242025
cnsp eps · cns pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$16.5MEPS: $-29.63View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis cnsp a buy · cnsp analyst rating
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$0.50Low
$4.92Current
$0.50Avg Target89.85% downside
$0.50High
cnsp price target · cnsp 12 month forecast

Total: 4 · Buy rate: 100.0%

The CNSP analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $0.50, representing -89.85% downside from the current price of $4.92.

Stock Performance

Full History
1D+0.10%
1W+3.20%
1M-31.34%
3M+70.24%
YTD-4.67%
1Y-59.51%
5Y-100.00%

About CNS Pharmaceuticals, Inc.

CEORami Levin
IPO DateNov 8, 2019
Employees4
CountryUS

CNS Pharmaceuticals, Inc. a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead…

what is cns pharmaceuticals, inc. · cnsp stock overview · cns pharmaceuticals, inc. company profile · who is cns pharmaceuticals, inc. ceo · cnsp NASDAQ · cns pharmaceuticals, inc. headquarters · cns pharmaceuticals, inc. business segments

About Stock Overview & Key Data

CNS Pharmaceuticals, Inc. (CNSP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 8, 2019. As of the latest trading session, CNSP stock price is $4.92, with a market capitalization of $2.8M. The stock has returned -59.51% over the past 12 months and -4.67% year-to-date.

According to 4 Wall Street analysts, the consensus rating for CNS Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $0.50. In fiscal year 2025, CNS Pharmaceuticals, Inc. reported revenue of — and net income of -$15.9M. For detailed data — including CNS Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CNS Pharmaceuticals, Inc. (CNSP) stock price is $4.92. The stock is traded on NASDAQ under the ticker symbol CNSP. The 52-week range is $1.90 – $12.84.

CNSP stock priceCNSP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice